Arkolith/Insider Trading/RNA/Form 4

Wilson Troy Edward

DirectorAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Sep 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)15K$12.48$181K84K
Sep 5, 2025Sell(S)15K$50.00$750K54K
Sep 5, 2025Sell(S)15K$50.00$725K69K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)15K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-25-000177) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML